Item 5.07 Submission of Matters to a Vote of Security Holders
(a) The 2022 Annual Meeting of Stockholders (the "Annual Meeting") of the
Company was held on
(b) There were 43,126,069 shares of Common Stock outstanding eligible to be
voted at the Annual Meeting, 4,203,576 shares of Digital Voting Series A-1
Preferred Stock (the "Series A-1 Preferred Stock") outstanding eligible to be
voted at the Annual Meeting, and 356,713 shares of Voting Series B Preferred
Stock (the "Series B Preferred Stock") outstanding eligible to be voted at the
Annual Meeting. Such Common Stock, Series A-1 Preferred Stock and Series B
Preferred Stock (together, the "Voting Shares") outstanding eligible to be voted
at the Annual Meeting totaled 47,686,358, of which 3,573,972 shares of Series
A-1 Preferred Stock, 316,760 shares of Series B Preferred Stock, and 33,849,107
shares of Common Stock were presented in person or represented by proxy at the
Annual Meeting, which constituted a quorum to conduct business. At the Annual
Meeting, the stockholders of the Company: (1) elected three directors to a
three-year term; (2) ratified the appointment of
Proposal 1 - Election of Directors
The individuals named below were elected at the Annual Meeting as Class II members of the Board of Directors, to serve for a term of three years ending in 2025, by the following vote:
Voting Shares: Name For Withheld Broker Non-Votes Joseph J. Tabacco, Jr. 25,332,176 5,362,151 7,045,512 Dr. Robert J. Shapiro 30,325,196 369,131 7,045,512 Barbara H. Messing 29,829,733 864,594 7,045,512
Proposal 2 - Ratification of Appointment of Independent Registered Public Accounting Firm
The proposal to ratify the Audit Committee's appointment of
Voting Shares: For Against Abstain Broker Non-Votes 36,587,688 958,488 193,663 0
Proposal 3 - Series A-1 Preferred Proposal
The proposal to approve an amendment to the Amended and Restated Certificate of Designation of our Series A-1 Preferred Stock to make Series A-1 Preferred Stock automatically convert into common stock, was approved by the stockholders by the following vote:
Voting Shares: For Against Abstain Broker Non-Votes 30,242,463 376,238 75,626 7,045,512 Series A-1 Preferred Stock: For Against Abstain Broker Non-Votes 2,339,406 162,502 5,296 1,066,768 2
--------------------------------------------------------------------------------
Series A-1 Preferred Stock and Series B Preferred Stock:
For Against Abstain Broker Non-Votes 2,631,183 167,259 5,296 1,086,994
Proposal 4 - Series B Preferred Proposal
The proposal to approve an amendment to the Amended and Restated Certificate of Designation of our Series B Preferred Stock to make Series B Preferred Stock automatically convert into common stock, was approved by the stockholders by the following vote:
Voting Shares: For Against Abstain Broker Non-Votes 30,244,462 375,599 74,266 7,045,512 Series B Preferred Stock: For Against Abstain Broker Non-Votes 291,777 4,757 0 20,226
Series A-1 Preferred Stock and Series B Preferred Stock:
For Against Abstain Broker Non-Votes 2,631,963 164,877 6,898 1,086,994
Proposal 5 - Adjournment Proposal
The proposal to approve one or more adjournments of the Annual Meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the time of the Annual Meeting to approve either the Series A-1 Preferred Proposal or the Series B Preferred Proposal, was approved by the stockholders by the following vote:
Voting Shares: For Against Abstain Broker Non-Votes 29,579,275 998,848 25,231 7,045,512
Item 9.01 Financial Statements and Exhibits
(d) Exhibits Exhibit No. Description of Exhibit The XBRL tags on the cover page of this Form 8-K are embedded within 104 the Inline XBRL document. 3
--------------------------------------------------------------------------------
© Edgar Online, source